Plant-based meat is meat that is prepared from plants and is similar to conventional meat in appearance and taste. The plant-based meat is produced using ingredients such as wheat gluten, lentils, yuba, tofu, soybeans, and a variety of nuts. The main product types of plant-based meat are burger patties, sausages, strips, nuggets, meatballs, and other product types. Sausage is a meat product made of finely chopped and seasoned meat that can be fresh, smoked, or pickled and which is then usually stuffed into a casing. The various sources of plant-based meat are soy, wheat, pea, and other product types. The plant-based meat products are distributed through grocery stores, food and beverage specialty stores, convenience stores, restaurants, and online stores. The plant-based meat research report is one of a series of new reports from The Business Research Company that provides plant-based meat statistics, including plant-based meat industry global market size, regional shares, competitors with plant-based meat share, detailed plant-based meat segments, market trends and opportunities, and any further data you may need to thrive in the plant-based meat industry. This plant-based meat research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global plant-based-meat market size will grow from $5.67 billion in 2022 to $6.69 billion in 2023 at a compound annual growth rate (CAGR) of 17.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global plant-based-meat market size is expected to grow from $12.12 billion in 2027 at a CAGR of 16.0%. Increasing consumer awareness associated with the benefits of vegetarian diets is projected to contribute to the growth of the plant-based meat market. The vegetarian diet offers various benefits, such as low insulin levels, a decreased rate of heart disease, and improved kidney functions. According to the International Food Information Council survey in August 2021, a US-based non-profit organization for a non-profit organization for food, beverages, and agriculture, Over the past year, the majority of Americans have eaten plant-based meat substitutes, with 2 in 5 doing so on a daily or weekly basis, which Top motives for choosing plant-based substitutes are their healthfulness and availability as a source of high-quality protein. Moreover, rising consumer awareness of animal rights through global welfare organizations such as animal aid unlimited (AAU) and people for the ethical treatment of animals (PETA) is to boost the demand for plant-based meat products, which in turn, is predicted to uptake the revenues of plant-based meat market over the forecast period. The high prices of plant-based meat products in comparison with regular meat products is a major restraint on the growth of the plant-based meat market. The major players dealing in plant-based meat products are beyond burger and impossible burger. At Whole Foods, an America-based multinational supermarket chain, the retail price of beyond burger is USD 12 a pound, whereas regular ground beef burger costs for less than half i.e. USD 5 a pound. Thus, the differences in the prices of plant-based meat products and regular meat products are predicted to hinder the growth of the market over the upcoming years. The increasing launch of new innovative products that are made from plant-based meat is a major trend in the plant-based meat market. For instance, in January 2020, Impossible Foods Inc., a US-based company operating in plant-based substitutes for meat products, launched its plant-based pork and sausage, which contains no gluten, no animal hormones, and no antibiotics. The plant-based, pre-seasoned product can be used in any recipe or dish that calls for animal-derived sausage or pork. In April 2021, Brazilian-based JBS SA, a meat processing company, announced that it would acquire Vivera, a European plant-based food company, for €341 million ($410 million). The deal includes three manufacturing facilities and a research and development centre located in the Netherlands. This acquisition is an important step to strengthen JBS SA's global plant-based protein platform. For the same reason, Vivera will give JBS a stronghold in the plant-based sector, with technological knowledge and capacity for innovation. Vivera produces a range of plant-based meat replacement products, and these products are distributed to retailers in more than 25 countries across Europe. Major players in the plant-based meat market are, Amy’s Kitchen, The Vegetarian Butcher, Maple Leaf Foods, Beyond Meat, Impossible Foods, Greenleaf Foods, Hungry Planet, Next Level, Abbots Butcher Asia-Pacific was the largest region in the plant-based meat market in 2022. Western Europe was the second-largest region in the global plant-based-meat market. The regions covered in the global plant-based-meat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the plant-based meat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The plant-based meat market consists of sales of products in the form of a burger patty, crumbles, nuggets, sausages, and other plant-based meat products. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global plant-based-meat market is segmented - 1) By Product Type: Burger Patties, Sausages, Strips, Nuggets, Meatballs, Other Product Types 2) By Source: Soy, Wheat, Pea, Other Sources 3) By Distribution Channel: Grocery Stores, Food & Drinks Specialty Stores, Convenience Stores, Restaurants, Online Stores

Protein expression is a process in which proteins are synthesized, modified, regulated, and controlled in living organisms according to the host cell. Protein expression in the context of protein research can now also refer to the application of lab procedures necessary for protein production. The main product types for protein expression are reagents, competent cells, expression vectors, services, and instruments. A reagent is a substance or compound that is added to a system in order to produce a chemical reaction or to determine whether or not a reaction occurred. The various forms of protein expression include yeast expression, mammalian expression, algae expression, insect expression, bacterial expression, and cell-free expression that are used for therapeutic, industrial, and research applications. The different end users involve pharmaceutical and biotechnology companies, academic research, and contract research organizations. The protein expression market research report is one of a series of new reports from The Business Research Company that provides protein expression market statistics, including protein expression industry global market size, regional shares, competitors with a protein expression market share, detailed protein expression market segments, market trends and opportunities, and any further data you may need to thrive in the protein expression industry. This protein expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global protein expression market will grow from $2.87 billion in 2022 to $3.19 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global protein expression market is expected to grow to $4.96 billion in 2027 at a CAGR of 11.6%. An increase in demand for biologics to counter various genetic disorders and chronic diseases is one the major factors driving the research and sales of protein expression market. Biologics is a medicine produced from living organisms or contains components of living organisms such as protein, tissue, genes, allergens, cells, blood components, blood, and vaccines. The increasing use of biologics (therapeutic protein and others) to cure chronic diseases such as cancer, cardiovascular conditions and genetic disorders, is increasing the demand for protein expression devices and equipment. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in the year 2020. Hence the rising demand for biologics is driving the protein expression market. For instance, according to an article published by Chemistry World, analysts stated that the biologics market hold a market share of more than a quarter of the entire pharmaceutical market in 2020. The global biologics market is expected to grow at 14.7% during 2021-2023. Government regulations related to protein therapeutics and the production of biologics may hinder the protein expression market growth. Government regulations on biologics to undergo rigorous preclinical and clinical trials prior to regulatory approval, and time-consuming process for approval of biologics with regards to health and the safety of any individual are restraining the market growth. Marketing and distribution of biologics including insulin, hormones, therapeutic antibodies, and vaccines depends upon the successful completion of clinical trials, which is a long, expensive, and uncertain process. According to FDA, for an approval of new biologic, Under the regulations (21 CFR 314.81(b)(2)(vii) and 601.70, a clinical trial approval usually takes 10- 12 months where firms are required to submit a report annually on the status of clinical safety, clinical efficiency, clinical pharmacology, and nonclinical toxicology study. Companies in the industry are increasingly adopting Microfluidics technology to enhance protein expression tests in order to reduce the time, cost, labor, and increase in the accuracy and performance. The microfluidics technology effectively analyzes biological samples than the traditional (macroscale) instruments. Microfluidics technology is used to measure the expression of proteins on cells and optimizes the output to generate results regarding protein expression. Therapeutics-on-a-chip (TOC) uses microfluidic platform and is able to synthesize proteins in a point-of-care setting to reduce cost associated with storage and transportation of therapeutic proteins. For instance, companies such as MissionBio, NanoCellect Biomedical, RainDance Technologies and Sphere fluidics have implemented this technology in protein expression test. The Protein Expression market in the U.S. is governed by the Food and Drug Administration (FDA) which lays down a series of guidelines for the manufacturers and retailers of this industry. Within FDA, Centre for Drug Evaluation and research (CDER) regulates biological products under FDA 101 which includes gene therapy products and vaccines. These regulations ensure the quality, safety, and efficacy of biological therapeutics products, and speed up innovations that make these products safer, and effective. The US FDA announced a fast-track initiative to review its drugs and biologics policy to speed the availability of therapies to patients with serious conditions, orphan drugs for rare disease, while preserving the safety and efficacy standards. FDA also removed a rule (Section 610.21 of the FDA code) that specified minimal potency limits for certain antibodies and antigens. The European Medicines Agency has also introduced policies that include a provision to waive the scientific advice fee, which encourages more academic groups and small companies to propose candidates for biologics. Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs, Promega Corporation, Qiagen, Takara Bio, Merck KGaA, Genscript Biotech Corporation, Life Technologies Corporation, Sigma-Aldrich Corporation, Lucigen Corporation, Synthetic Genomics Inc., Becton, Dickinson & Company, Lonza Group Ltd., Accelagen Inc., Geneva Biotech, Viva Biotech, Becton, Dickinson & Company, Sengenics, ARTES Biotechnology GmbH, Addgene Inc., Profacgen, ProteoGenix, Peak Proteins Ltd., Domainex Ltd., Jena Bioscience GmbH, EMD Millipore, and Oxford Expression Technologies Ltd. North America was the largest region in the protein expression market in 2022. Western Europe was the second largest region in the global protein expression market. The regions covered in the global protein expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the protein expression market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The protein expression market includes revenue earned by instruments, expression kits, and systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global protein expression market is segmented - 1) By Protein Expression: Yeast Expression, Mammalian Expression, Algae Expression, Insect Expression, Bacterial Expression, Cell-free Expression 2) By End Use: Pharmaceutical And Biotechnological Companies, Academic Research, Contract Research Organizations 3) By Product: Reagents, Competent Cells, Expression vectors, Services, Instruments 4) By Application: Therapeutic, Industrial, Research

Protein labelling refers to the process of detecting or purifying the labelled protein and its binding partners by using the proper molecular labels. Most biological research uses one of three basic categories of protein labels: biotin, enzyme conjugates, or fluorescence probes. The main types of products in protein labelling are reagents, proteins, enzymes, probes or tags, and monoclonal antibodies. Monoclonal antibodies are created by cloning a single white blood cell. Every subsequent antibody generated in this manner may be traced back to a single parent cell. The different labelling methods include in-vitro labeling, and in-vivo labelling and are used in cell-based assays, fluorescence microscopy, immunological techniques, mass spectrometry, and protein microassays. The protein labelling market research report is one of a series of new reports from The Business Research Company that provides protein labelling market statistics, including the industry's global market size, regional shares, competitors with a protein labelling market share, detailed protein labelling market segments, market trends and opportunities, and any further data you may need to thrive in the protein labelling industry. This protein labelling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global protein labelling market grew from $2.13 billion in 2022 to $2.35 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The protein labelling market is expected to grow from $3.49 billion in 2027 at a CAGR of 10.4%. Increased spending on the R&D of proteomics and genomics is driving the growth of the protein labelling reagents market. Proteomics is the study of the overall protein content of a cell, tissue, or organism. Protein labelling methods before separation and analysis are essential during proteomic profiling approaches. For instance, the National Institutes of Health (NIH) of the United States, funded $37 billion for biomedical research. This funding is for life sciences research that supports study at a molecular level for the understanding of fundamental processes by which diseases develop, the identification of biomarkers that signal the presence of disease, or identification of genes or proteins responsible for the disease. The Novo Nordisk Foundation granted a grant of up to $1.5 million to the University of Copenhagen to establish a mass spectrometry facility, which marks a new and exciting step in protein research. Therefore, the increased spending on research and development of proteomics and genomics is driving the market. Drawbacks related to protein labelling techniques are expected to hinder the market. Label-free techniques are preferred over labelled techniques because of the drawbacks associated with them, such as wet-lab complexity and flexibility. While label-free samples can be measured without much preparation, wet lab pre-treatment is required for all labelling techniques. Samples must be labelled with metabolic (e.g. SILAC) or chemical (e.g. iTRAQ or TMT) reagents and the different conditions has to be combined. Therefore, label-free techniques are less prone to wet lab errors than labelling techniques. Label-free approaches have the advantage of being highly adaptable, even after the study has begun. New samples can be included at any time, but labelled approaches require the same number (n) of each condition. New samples may not be included in the study if they cannot be physically mixed and measured with the control. Labeled techniques such as the Super-SILAC approach reduce this problem but must also be carefully planned. These disadvantages are making label-free techniques preferable. Therefore, drawbacks associated with protein labeling techniques are expected to hinder the market. Companies in the protein labelling market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated as well as academic and research institutions in this market by way of partnerships, in or out-licensing deals, this trend has been increasing over recent years. For instance, recombinant protein manufacturer enGenes Biotech GmbH (enGenes) announced a collaboration with ACIB GmbH for protein labeling. In January 2020, Abcam, a UK-based protein research tools producer and seller, announced its decision to acquire Expedeon's Proteomics and Immunology business, which includes Innova and TGR Biosciences. Expedeon technology supports a diverse set of labels, including enzymes, metals, oligos, and fluorescent proteins. Abcam will combine the newly acquired capture and conjugation technologies with its extensive antibody and protein expertise to expand and enhance its portfolio of off-the-shelf, and custom reagents and tools. Expedeon is a Germany-based manufacturer of protein discovery and analysis products used for protein and drug research. Major players in the protein labelling market are Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer, Inc., General Electric Company, F. Hoffmann-La Roche AG, AGILENT TECHNOLOGIES INC., BIO-RAD LABORATORIES, Kirkegaard & Perry Laboratories, LI-COR Inc. and Kaneka Corporation. North America was the largest region in the protein labeling market in 2022. The regions covered in the global protein labelling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the protein labelling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The protein labeling market includes revenues earned by entities by detecting or purifying the labelled protein and its binding partners. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global protein labelling market is segmented - 1) By Product: Reagents, Protein, Enzymes, Probes/ Tags, Monoclonal Antibodies 2) By Labeling Method: In-vitro Labeling, In-vivo Labeling 3) By Application: Cell Based-Assay, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, Protein Micro Assay

Protein inhibitors refer to compounds that interfere with the steps directly involved in the production of new proteins in cells. Protein inhibitors operate at the ribosome level, benefiting from the significant variations between prokaryotic and eukaryotic ribosome architectures. The main product types of protein inhibitors are protein kinase inhibitors, monoclonal antibodies, and others. Monoclonal antibodies are laboratory-created molecules designed to act as substitute antibodies, restoring, enhancing, modifying, or mimicking the immune system's attack on unwanted cells, such as cancer cells. The protein inhibitors are used in the treatment of oncology, inflammatory diseases, and others, and are distributed by hospital pharmacies, independent pharmacies, and online pharmacies. The protein inhibitors market research report is one of a series of new reports from The Business Research Company that provides protein inhibitors market statistics, including protein inhibitors industry global market size, regional shares, competitors with a protein inhibitors market share, detailed protein inhibitors market segments, market trends and opportunities, and any further data you may need to thrive in the protein inhibitors industry. This protein inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global protein inhibitors market grew from $68.17 billion in 2022 to $74.3 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The protein inhibitors market is expected to grow from $105.43 billion in 2027 at a CAGR of 9.1%. The increasing prevalence of chronic diseases is predicted to contribute to the growth of the protein inhibitors market over the forecast period. Chronic diseases such as cancer, cardiovascular diseases, and autoimmune diseases are becoming more prevalent. For instance, in May 2022, according to the World Health Organization, chronic diseases are expected to become the seventh leading cause of death globally by the end of 2030.In the USA, the number reached 157 million in 2020, with 87 million people having multiple conditions. Protein inhibitors are used for the treatment of these diseases attributing to fewer adverse effects and higher efficacy. Therefore, an increasing number of people with chronic diseases are anticipated to propel the demand for protein inhibitors market. The high cost of protein inhibitors used for cancer is anticipated to limit the growth of the protein inhibitors market shortly. Monoclonal antibodies are a type of protein made in the laboratory to bind substances in the body including cancer cells and are used to treat various types of cancer. Monoclonal antibody therapies are considered to be costlier when used for cancer. For instance, according to the National Center for Biotechnology Information, the average price of monoclonal antibodies was $96,731 for 34 monoclonal antibody indication combinations. Oncology and hematology monoclonal antibodies represented 40% of approved monoclonal antibody indication combinations, yet accounted for more than 85% of those priced at $100,000 or higher. The price of oncology or hematology monoclonal antibodies was $149,622 higher than those used in metabolic or cardiovascular disorders, $106,830 higher than in ophthalmology, $128,856 higher than in infectious diseases or allergies, and $98,981 higher than in immunology. Thus, the high cost of protein inhibitors including monoclonal antibodies for the treatment of cancer is expected to hinder the market’s growth. Companies in the protein inhibitors market are increasingly investing in various strategic initiatives such as partnerships and collaborations to develop new drugs to meet the market demand. Strategic collaborations and partnership agreements help companies to expand their existing product portfolio and geographical presence. For instance, in February 2020, Catalent, Inc., a USA-based provider of delivery technologies, drug manufacturing, gene therapies, biologics, and consumer healthcare products announced a partnership agreement with Zumutor Biologics Inc., an immune-oncology company based in the USA to manufacture ZM008, a monoclonal antibody targeting solid tumors. Moreover, in February 2021, Eli Lilly and Company, a USA-based pharmaceutical company, and Rigel Pharmaceuticals, Inc., a USA-based biotechnology company, announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for all indications, including autoimmune and inflammatory diseases. In June 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, acquired ReViral for $525 million. The acquisition strengthens Pfizer's commitment to creating both medications and vaccines to help fight the respiratory syncytial virus while also expanding its anti-infective portfolio (RSV). ReViral is a UK-based clinical-stage biopharmaceutical company pioneering in the discovery and development of innovative antiviral drugs for disorders brought on by the respiratory syncytial virus. Major players in the protein inhibitors market are Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, GlaxoSmithKline, Pfizer, Boehringer Ingelheim, and F. Hoffmann-La Roche. North America was the largest region in the protein inhibitors market in 2022. The regions covered in the global protein inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the global protein inhibitors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The protein inhibitors market consists of sales of erythromycin, tetracycline, chloramphenicol, and aminoglycosides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global protein inhibitors market is segmented - 1)By Product: Protein Kinase Inhibitors, Monoclonal Antibody, Other Products 2)By Application: Oncology, Inflamatory Diseases, Other Applications 3)By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies

Protein supplements refer to a nutritional supplement that contains protein and is intended to supplement the diet. A protein supplement helps in building muscle, repairing tissue, and producing enzymes and hormones. It also aids in weight loss and assists in toning of muscles for athletes. The main types of protein supplements include protein powder, protein bars, and ready-to-drink products. Protein powder refers to powdered forms of protein that are derived from plants (soybeans, peas, rice, potatoes, or hemp), eggs, or milk (casein or whey protein). Other components, such as extra sugar, artificial flavors, thickeners, vitamins, and minerals, are added to enhance the flavor and functionality of the powder. Based on raw material, the protein supplements are differentiated by casein protein supplements, whey protein supplements, egg protein supplements, MPC protein supplements, and soy protein supplements. The animal-derived and plant-derived protein supplements are sold through supermarkets, hypermarkets, online stores, and drug stores. The protein supplements market research report is one of a series of new reports from The Business Research Company that provides protein supplements market statistics, including protein supplements industry global market size, regional shares, competitors with a protein supplements market share, detailed protein supplements market segments, market trends and opportunities, and any further data you may need to thrive in the protein supplements industry. This protein supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global protein supplements market size grew from $18.75 billion in 2022 to $20.62 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The protein supplements market size is expected to grow to $29.51 billion in 2027 at a CAGR of 9.4%. The rise in customer preference for food supplements is driving the protein supplements market. Food Supplements are intended to make up for dietary deficiencies among individuals through their regular diet. The desire to lead active and healthy lifestyles has increased participation in sports and fitness activities, driving the demand for food supplements, especially protein supplements. According to the Council for Responsible Nutrition survey 2020, a US-based trade association for ingredient suppliers and manufacturers in the dietary supplement industry, approximately 43% of supplement users have altered their supplement regimens after the pandemic, whereas 91% of these users report an increase in supplement intake, including the addition of new supplements to an existing routine (46%), the taking of the same supplements more frequently (25%), or the increasing of doses (22%). Thus, an increase in customer preference for food supplements is expected to boost the demand for protein supplements during the forecast period. Strategic partnership is a key trend gaining popularity in the protein supplements market. The companies operating in the protein supplement sector are focusing on entering into strategic partnerships to expand their market reach and leverage each other's resources in new product development & marketing activities. In October 2021, a New Jersey-based company that creates collagen supplements entered into a partnership with Entenmann's, owed by Bimbo Bakeries USA. The partnership aims to create a new collagen protein powder with Entenmann's chocolate chip cookies as inspiration. Entenmann is a US-based company that manufactures and delivers baked goods. In February 2022, Nestle Health Sciences, a Switzerland-based provider of nutrition solutions, diagnostics devices, and drugs for specific target areas acquired a majority stake in Orgain, for an undisclosed amount. Through this, Nestle is focused on expanding its product portfolio in the plant-based protein supplement sector and enhancing its business presence in the fast-growing plant-based product sector across the globe. Orgain is a California-based provider of plant-based nutritional products. Major players in the protein supplements market are GlaxoSmithKline (GSK), Glanbia PLC, ABBOTT LABORATORIES (ABBOTT), Amway Corporation, Herbalife International of America, Inc., PepsiCo, AMCO Proteins, QuestNutrition, GNC Holdings, Maker Nutrition LLC, SUPPLEFORM, Vitaco Health Limited, Garden of Life, Melaleuca Inc., Atlantic Multipower UK Limited, International Dehydrated Foods, Inc., Scitec Nutrition, and BRF. North America was the largest region in the protein supplements market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein supplements market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the protein supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The protein supplements market consists of sales of soybean meal, essential amino acid, protein intake, proteins, amino acids, whey protein. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global protein supplements market is segmented - 1) By Type: Protein Powder, Protein Bar, Ready to Drink 2) By Source: Plant-based, Animal-based 3) By Raw Material: Casein Protein Supplements, Whey Protein Supplements, Egg Protein Supplements, MPC Protein Supplements, Soy Protein Supplements 4) By Distribution Channel: Supermarkets & Hypermarkets, Online Stores, Drug Stores

The protein shampoo is a shampoo enriched with keratin to provide additional keratin to the hair follicles that coat the hair strands and provide protection to the hair. The protein shampoo market consists of the sales of protein shampoo is used as cosmetic products in human hair care. Protein shampoo products consist of keratin protein, collagen, and silk, which assist in increasing the elasticity of hair and strengthening, nourishing, and cleansing the hair. The main products of the protein shampoo are standard protein shampoo, anti-dandruff protein shampoo, anti-frizz protein shampoo, and other products. Standard protein shampoo refers to a type of shampoo designed to cleanse, strengthen and increase the elasticity of the hair. The ingredients used in protein shampoo include natural and organic, and chemicals. The various distribution channels involved in protein shampoo include online, hypermarkets and supermarkets, pharmaceutical and drug stores, and other distribution. The end-users of protein shampoo include adults and kids. The protein shampoo market research report is one of a series of new reports from The Business Research Company that provides protein shampoo market statistics, including protein shampoo industry global market size, regional shares, competitors with a protein shampoo market share, detailed protein shampoo market segments, market trends and opportunities, and any further data you may need to thrive in the protein shampoo industry. This protein shampoo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global protein shampoo market size grew from $1.79 billion in 2022 to $1.94 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The protein shampoo market size is expected to grow to $2.69 billion in 2027 at a CAGR of 8.5%. An increasing prevalence of hair and scalp-related diseases is expected to propel the growth of the protein shampoo market going forward. Rapid growth in pollution, increasing exposure of human hair to hazardous chemicals, and rapidly changing weather patterns have led to an increase in the prevalence of hair and scalp-related diseases across the globe. The individuals infected with these diseases or issues are spending on highly effective protein shampoo products, as they are formulated to be very mild, and non-irritating products that help to minimize hair and scalp-related diseases. For instance, in April 2020, according to the American Academy of Dermatology Association article, a US-based Peer-reviewed journal, on average, 80 million people suffer from hair issues, where around 50 million are men and 30 million are women a year in the United States. Therefore, the increasing prevalence of hair and scalp-related diseases is expected to boost demand for protein shampoo during the forecast period. Product innovation is the key trend gaining popularity in the protein shampoo market. Major companies operating in the protein shampoo market are focused on developing new product innovations to strengthen their position in the market. For instance, in May 2022, Medimix, the flagship brand of AVA Group, an Indian-based company manufacturing protein shampoos launched its total care shampoo in the hair care portfolio. Total care shampoo consists of wheat protein and other nine natural herbs such as tea tree oil, rosemary oil, neem, wild ginger, and others in a unique formula, which will help in minimizing hair loss, acting as anti-dandruff, and conditioning hair. In July 2022, Henkel, a Germany-based beauty care brand, acquired Shiseido's Professional hair business for an undisclosed amount. This acquisition combines two successful premium brands resulting in an alluring portfolio and an innovative combination of Western and Asian beauty knowledge, innovation, and education. Shiseido is a Japan-based cosmetics company that offers hair care products including protein shampoo. Major players in the protein shampoo market are L’Oréal, Procter & Gamble, Unilever, Shiseido Company Limited, The Estée Lauder Companies Inc., Keratin Complex, Atlantic Coast Brands, McBride Research Laboratories Inc., PureBiology, Klorane, Kohli Herbal Products, KeraGreen, CavinKare Group, Amishi Consumer Technologies Private Limited (The Moms Co.), Herbario Cosmetics Private Limited, and Skin Secrets. North America was the largest region in the protein shampoo market in 2022, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the protein shampoo market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the protein shampoo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The protein shampoo market consists of sales of shampoo that contains hydrolyzed (wheat, oat, soy) protein, hydrolyzed vegetable protein, hydrolyzed keratin, and hydrolyzed collagen. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global protein shampoo market is segmented - 1) By Product: Standard Protein Shampoo, Anti-dandruff Protein Shampoo, Anti-frizz Protein Shampoo, Other Products 2) By Ingredient: Natural and Organic, Chemical-based 3) By Distribution Channel: Online, E-commerce Websites, Company-owned Websites, Offline, Hypermarkets and Supermarkets, Pharmaceutical and Drug Stores, Other Distribution Channels 4) By End User: Adults, Kids

Protein purification and isolation refers to the procedures used to separate an interesting protein from its surroundings. In other words, from a cell culture created in a lab or from the other natural chemicals naturally surrounding the proteins in the natural niche in a host organism. This process helps to identify the existence of the protein from the source, based on differences in their properties. The main types of protein purification and isolation are instruments and consumables. The instruments are devices used to carry out protein purification and isolation processes that include extraction, precipitation, differential solubilization, ultracentrifugation, and chromatographic methods. The various technologies used are ultrafiltration, precipitation, preparative chromatography, electrophoresis, western blotting, dialysis and diafiltration and centrifugation and various end users include academic medical institutes, hospitals and diagnostic centers, pharmaceutical and biotechnology companies and contract research organizations. The applications include drug screening, protein-protein interaction studies, biomarker discovery, target identification, protein therapeutics, disease diagnostics and monitoring. The protein purification and isolation market research report is one of a series of new reports from The Business Research Company that provides protein purification and isolation market statistics, including protein purification and isolation industry global market size, regional shares, competitors with an protein purification and isolation market share, detailed protein purification and isolation market segments, market trends and opportunities, and any further data you may need to thrive in the protein purification and isolation industry. This protein purification and isolation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global protein purification and isolation market size grew from $7.77 billion in 2022 to $8.58 billion in 2023 at a compound annual growth rate (CAGR) of 10.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The protein purification and isolation market size is expected to grow to $12.44 billion in 2027 at a CAGR of 9.7%. An increase in spending by governments on research and development in pharmaceutical and biotechnology is expected to propel the growth of the protein purification and isolation market going forward. Research and development refer to gathering knowledge to create new products or discover new ways to improve their existing products and services. An increase in spending on research and development helps to develop advanced protein purification processes and also provides various other benefits such as purified growth factors of hormones, DNA polymerases, and reverse transcriptase. For instance, according to the Indian Brand Equity Foundation, an India-based export promotion agency, the Indian government has allocated USD 10.35 billion and the Department of Health Research has allocated USD 365.68 billion respectively towards the promotion of the pharma sector for the year 2021. Further, according to The Good Food Institute, a US-based alternative protein innovation organization, in 2021, the US department of agriculture and National science, a US-based food safety organization spent USD50 million on advancements in the development of alternative proteins. Therefore, the Increasing spending by governments on research and development in pharmaceutical and biotechnology is driving the growth of the protein purification and isolation markets. Technological advancements are a key trend gaining popularity in the protein purification and isolation market. Major companies operating in the market are focused on developing new technological innovations to gain a competitive advantage. For instance, in April 2021, Thermo Fisher Scientific, a US-based manufacturer of scientific instrumentation, and medical software services launched KingFisher Apex Purification System. It is a high-protein sample purification instrument designed for scientists who work on extracting DNA, proteins, and cells. This system helps in protein and cell isolation and provides a customized process for flexible, reproducible, and fast sample preparation without additional expense. With the help of automation technology, it provides error-free reports and produces high-quality nucleic acids and proteins. This protein purification device can process 24 to 96 samples in 25 to 65 minutes. In November 2021, Beximco Pharmaceuticals Ltd., a Bangladesh-based pharmaceutical company acquired Sanofi Bangladesh for an undisclosed amount. Through this acquisition, Beximco is expected to strengthen its position in key therapeutic areas to drive sustainable revenue and profit growth. Sanofi is a France-based healthcare company that is involved in protein purification, and manufacturing of medicines and vaccines. Major players in the protein purification and isolation market are Abcam PLC, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., BioVision Inc., Norgen Biotek Corp., GE Healthcare, GEA Group AG, Expedeon Ltd., Creative Biostructure, Qiagen, Geno Technology Inc., The Merck Group, Labome, Promega Corporation, OPRL Biosciences Pvt.Ltd., Purolite, Takara Bio Inc., Roche Applied Science, and Sigma-Aldrich. North America was the largest region in the protein purification and isolation market in 2022. The regions covered in the protein purification and isolation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the protein purification and isolation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The protein purification and isolation market includes revenues earned by entities by isolating one or a few proteins from a complex mixture. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced.It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global protein purification and isolation market is segmented - 1) By Product: Instruments, Consumables 2) By Technology: Ultrafiltration, Precipitation, Preparative Chromatography, Electrophoresis, Western Blotting, Dialysis and Diafiltration, Centrifugation 3) By Application: Drug Screening, Protein-Protein Interaction Studies, Biomarker Discovery, Target Identification, Protein Therapeutics, Disease Diagnostics and Monitoring 4) By End User: Academic Medical Institutes, Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organizations

Foods are defined as processed products of plants, and animals that contain essential nutrients such as protein, carbohydrates, fat, and other nutrients consumed by humans. Beverages are defined as potable drinks which have thirst quenching refreshing, stimulating, and nourishing properties. The main type of food and beverages are alcoholic – beverages, nonalcoholic – beverages, grain products, bakery & confectionary, other foods products, frozen, canned, and dried food, dairy food, meat, poultry and seafood, syrup, seasoning, oils, & general food, animal and pet food, and tobacco products. Alcoholic beverages include beverages that contain varying amounts of alcohol (ethanol). The various typesdistinct types of distribution channels are supermarkets/hypermarkets, convenience stores, e-commerce, and Other Distribution Channels. The different typesseveral types of nature include organic and conventional. The food and beverages research report is one of a series of new reports from The Business Research Company that provides food and beverages statistics, including food and beverages industry global market size, regional shares, competitors with food and beverages share, detailed food and beverages segments, market trends and opportunities, and any further data you may need to thrive in the food and beverages industry. This food and beverages research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global food and beverages market grew from $6,729.54 billion in 2022 to $7,221.73 billion in 2023 at a compound annual growth rate (CAGR) of 7.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The food and beverages market is expected to grow to $9,225.37 billion in 2027 at a CAGR of 6.3%. Many countries across the globe are experiencing falling prices of crops due to overcapacity; this is expected to result in low raw material costs for food and beverage companies. For instance, in November 2022, according to the report Frontline, an India-based national magazine on agriculture, the bailout package of Rs 7000 crore, announced by the Cabinet Committee on Economic Affairs, for farmers involved in the sugar production sectors to fix the minimum selling price of refined sugar of Rs 29 per kilogram (prices dropped to Rs 23-24 recently due to overproduction and to create a buffer stock of 3 million tonnes of sugar for one year. Thus, the overproduction of certain crops is likely to result in higher profit margins for food and beverage companies. Higher profit margins will enable food and beverage companies to increase their productivity and drive the market going forward. The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the food and beverages market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and spread globally including Western Europe, North America, and Asia. Food and beverage manufacturers depend on the supply of raw materials from domestic and international suppliers. As many governments restricted the movement of goods across countries and locally, manufacturers had to halt production due to a lack of raw materials. Also, restrictions on the trade of non-essential goods and fear of contamination through manufacturing facilities contributed to the decline. The outbreak had a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the food and beverages market will recover from the shock across the forecast period as it is a 'black swan event and not related to ongoing or fundamental weaknesses in the market or the global economy. Frozen food manufacturers are using technologies such as individual quick freezing (IQF) to improve the yield and quality of frozen foods. The IQF method involves transferring the individual food items on a conveyor belt into a blast freezer that quickly freezes the items. With the IQF method, every individual piece of food is frozen separately, as opposed to bulk or block freezing. This method boosts yield by 1.5-3% and results in better quality products with high nutritional value and less wastage. Examples of IQF foods include fruits such as blueberries, strawberries, and peaches, and vegetables such as corn, peas, and green beans. The global IQF vegetable market is expected to reach $2 billion by 2026, thus indicating significant demand for IQF food products in the future. Major companies in the food and beverages market include Nestle S.A., JBS S.A., PepsiCo Inc., Anheuser-Busch InBev sa/nv, Tyson Foods Inc., Wilmar International Ltd., Archer-Daniels-Midland Company (ADM), The Coca-Cola Company, Imperial brands plc, Mars Incorporated. Asia-Pacific was the largest region in the food and beverages market in 2022. Western Europe was the second-largest region of the food and beverages market. The regions covered in the food and beverages market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the food and beverages market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The food and beverages market consists of sales of beer, wine and brandy, spirits, coffee and tea, soft drink and ice, flour, rice and malt, breakfast cereal, sugar and confectionery products, bread and bakery products, cookie, cracker, pasta, and tortilla, perishable prepared food, snack food, frozen food, canned and ambient food, milk and butter, cheese, dry, condensed, and evaporated dairy products, ice cream and frozen dessert, meat products, poultry, seafood, flavoring syrup and concentrate, seasoning and dressing, fats and oils, pet food, animal food, cigarettes, cigars and cigarillos, smoking and other tobacco products. The companies in the food and beverages industry process raw materials into food, pet food and tobacco products, package and distribute them through various distribution channels to both on-trade and off-trade establishments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global food and beverages market is segmented - 1) By Type: Alcoholic - Beverages, Non Alcoholic - Beverages, Grain Products, Bakery & Confectionary, Other Foods Products, Frozen, Canned and Dried Food, Dairy Food, Meat, Poultry And Seafood, Syrup, Seasoning, Oils, & General Food, Animal And Pet Food, Tobacco Products 2) By Distribution Channel: Supermarkets/Hypermarkets, Convenience Stores, E-Commerce, Other Distribution Channels 3) By Nature: Organic, Conventional Subsegments Covered: Beer, Wine And Brandy, Spirits, Coffee And Tea, Soft Drink And Ice, Flour, Rice And Malt, Other Grain Products, Breakfast Cereal, Sugar And Confectionery Products, Bread And Bakery Products, Cookie, Cracker, Pasta, And Tortilla, Perishable Prepared Food, Snack Food, All Other Miscellaneous Food, Frozen Food, Canned And Ambient Food, Milk And Butter, Cheese, Dry, Condensed, And Evaporated Dairy Products, Ice Cream And Frozen Dessert, Meat Products, Poultry, Seafood, Flavoring Syrup And Concentrate, Seasoning And Dressing, Fats And Oils, Pet Food, Animal Food, Cigarettes, Cigars And Cigarillos, Smoking And Other Tobacco Products